Michael Frid

Director of Formulation
Chemistry & Co-Founder

Michael is an accomplished drug and formulation chemist with over fifteen years of pharmaceutical drug design expertise. He has worked for Wolfe Labs and as the lead scientist at Minerva Biotechnologies, and is Vice President of Preclinical at Felicitex Therapeutics, which recently won an exclusive license from a French diagnostics company for lead-stage anti-cancer compounds. He is an accomplished scientist with extensive experience in intellectual property development, in vitro experimentation, experimental design and formulation chemistry. He graduated cum laude in Chemistry from New York University and received his Ph.D. in Organic Chemistry from Massachusetts Institute of Technology.